This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager.
Dismiss

IP licensing and business: Feb. 27-March 12

By Nick Robertson ( March 12, 2026, 21:29 GMT | Insight) -- Moderna agreed to settle a COVID-19 patent case for up to $2.25 billion, in what could be the largest patent infringement settlement figure in pharma history. Multiple patent pools also announced expansions.Genevant Sciences and Arbutus Biopharma broke records last week, announcing a settlement agreement with Moderna for patent infringement claims related to the COVID-19 vaccine that could reach up to $2.25 billion, the most ever in the pharmaceutical industry. Expansion in patent pools and a new major AI news licensing deal also dominated IP headlines....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login